Fractyl Health is a metabolic therapeutics company dedicated to developing transformative treatments for metabolic diseases, including type 2 diabetes and obesity. The mission of Fractyl Health is to shift the paradigm of metabolic disease management from merely addressing symptoms to providing durable, disease-modifying therapies that target the underlying causes of these conditions. The organization comprises a team of skilled professionals who are passionate about innovation and aim to create breakthrough therapies that can significantly improve patient lives. Fractyl values intellectual curiosity, collaboration, and a strong focus on results, fostering an environment where team members can thrive and contribute to meaningful advancements in healthcare. By combining expertise in biotechnology, engineering, and clinical research, Fractyl Health is poised to make a substantial impact in the field of metabolic health.